<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04993521</url>
  </required_header>
  <id_info>
    <org_study_id>BSCPB_Block</org_study_id>
    <nct_id>NCT04993521</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Total Thyroidectomy.</brief_title>
  <acronym>BSCPB_Block</acronym>
  <official_title>Ultrasound Guided Bilateral Superficial Cervical Plexus Block Versus Local Wound Infiltration in Patients Undergoing Total Thyroidectomy: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ahmed Mohamed Abdelrahman</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahmoud Ahmed Mewafy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abdelrhman Alshawadfy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haidi Abd-Elzaher</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamada Fathy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mohamed Faisal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study compared the efficacy of bilateral superficial cervical plexus block&#xD;
      (BSCPB) versus local wound infiltration (LWI) regarding the postoperative opioid consumption&#xD;
      in patients undergoing total thyroidectomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We performed a double-blind, randomised, controlled trial that recruited patients undergoing&#xD;
      total thyroidectomy at the Suez Canal University Hospital during the period between February&#xD;
      2019 and January 2021. Patients were eligible if they were older than 20 years, had an&#xD;
      American Association of Anesthesiologists' (ASA) level of I-II, and were scheduled for total&#xD;
      thyroidectomy. We excluded patients with documented allergies to the study's intervention&#xD;
      materials, moderate-to-severe obesity, &gt; 1st-degree heart block, chronic pulmonary or cardiac&#xD;
      diseases, hepatic or renal dysfunction, and/or coagulopathies. All patients were required to&#xD;
      fill out informed consent before enrollment.&#xD;
&#xD;
      Eligible patients were randomly allocated in a 1:1 ratio to receive BSCPB or LWI using the&#xD;
      computer software program (www. Randmizer.org) and allocation sequences were done using&#xD;
      opaque, closed envelopes. The BSCPB group received BSCBP (after general anaesthesia but&#xD;
      before the start of surgery) from two syringes containing ropivacaine 0.5 % and LWI with&#xD;
      saline. The LWI group received LWI with ropivacaine 0.5% and the BSCPB from two syringes&#xD;
      containing saline.&#xD;
&#xD;
      The primary outcome of the present study was postoperative opioid consumption in the first&#xD;
      postoperative day. The secondary outcomes included the total intraoperative fentanyl and&#xD;
      isoflurane consumption, time to first required analgesic, and VAS during the first 24 hours&#xD;
      postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">May 15, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A Randomized Controlled Study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative opioid consumption in the first postoperative day</measure>
    <time_frame>24 hours</time_frame>
    <description>postoperative opioid consumption in the first postoperative day in milligrams</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total intraoperative fentanyl (mg) and isoflurane consumption (ml)</measure>
    <time_frame>6 hours</time_frame>
    <description>total intraoperative fentanyl and isoflurane consumption in micrograms and ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to first required analgesic</measure>
    <time_frame>6 hours</time_frame>
    <description>time to first required analgesic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS (10 cm; range): Pain average (VAS) for the first 24 hours postoperatively</measure>
    <time_frame>every 6 hours until 24 hours postoperatively</time_frame>
    <description>VAS (10 cm; range) Pain average (VAS) for the first 24 hours postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Analgesia Obtained With a Local Wound Infiltration of Lidocain</condition>
  <condition>Analgesia Obtained With a Ultrasound Guided Cervical Plexus Block Using Lidocain</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>bilateral superficial cervical plexus block (BSCPB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analgesia obtained by a ultrasound guided cervical plexus block using lidocain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local wound infiltration (LWI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analgesia obtained by local wound infiltration of lidocain</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Block type</intervention_name>
    <description>Regular block type</description>
    <arm_group_label>bilateral superficial cervical plexus block (BSCPB)</arm_group_label>
    <arm_group_label>local wound infiltration (LWI)</arm_group_label>
    <other_name>Ultrasound guided bilateral superficial cervical plexus nerve block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ASA I-II, and were scheduled for total thyroidectomy&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        documented allergy to study's intervention, moderate-to-severe obesity, &gt; 1st-degree heart&#xD;
        block, chronic pulmonary or cardiac diseases, hepatic or renal dysfunction, and/or&#xD;
        coagulopathies.&#xD;
&#xD;
        All patients were required to fill the informed consent before enrollment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>July 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Folke Sjoberg</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Can be shared on reasonable terms</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

